Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Insulin resistance
by Highest Patent Value in the South Korea in 2020

The Insulin resistance top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Insulin resistance Key Players in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A condition where the body does not respond to insulin.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Drug development,
...[+2]
Avg patent value: 6.72 M
2
Avg patent value: 5.69 M
3
Avg patent value: 4.77 M
4
Petrochemical,Synthetic rubber,Health care,
...[+2]
Avg patent value: 3.95 M
5
Fair trade,Medicine,Clinical trial,
...[+2]
Avg patent value: 3.51 M
6
Avg patent value: 2.67 M
7
Avg patent value: 2.49 M
8
Avg patent value: 2.21 M
9
Avg patent value: 1.93 M
10
Avg patent value: 1.57 M
11
Avg patent value: 940,000
12
Avg patent value: 940,000
13
Avg patent value: 750,000
14
Avg patent value: 300,000
15
Avg patent value: 300,000
16
Avg patent value: 83,000
17
Insurance benefit,Insurance carriers,Insurance policy
Avg patent value: 59,000
18
Avg patent value: 51,000
19
Avg patent value: 47,000
20
Health care,Toxicity,Toxicokinetics,
...[+2]
Avg patent value: 39,000
Page generation time: Jul 20 2025